Titan International (TWI) reported a third-quarter loss of $0.03 per share, better than the consensus estimate of a $0.05 loss, a 40.0% earnings surprise. That is the only clean win in the headline. Earnings fell 175.0% from the year-ago quarter. Revenue from continuing operations was $335.18 million, 25.3% below the $448.83 million consensus and down 28.1% year over year. The revenue miss needs context. Titan now reports its Italtractor ITM undercarriage business as discontinued operations ahead of its sale to USCO. Including ITM, sales were $454 million, above the midpoint of the company's $440-460 million guidance, and Adjusted EBITDA of $28 million fell within the $27-33 million range. Consensus appears not to have fully adjusted for the reclassification, so the revenue shortfall is largely a comparability issue. The real story is the outlook, and that was unambiguously weaker.

The quality of the quarter deserves scrutiny beyond the EPS beat. On a continuing-operations basis, Adjusted EBITDA was just $16 million on a 14.7% gross margin. The segment detail shows the agricultural business deteriorating faster than earlier in the year:

• Ag sales fell 12%.
• Ag gross margin collapsed to 7.6% from 13.2% a year ago.
• That margin was 11.4% in Q2 and 12.1% in Q1, so the decline is accelerating, not a one-quarter blip.
• Consumer sales swung from 27% growth in Q2 to a 3% decline. Management attributed the drop to an abnormally strong, tariff-driven year-ago comparison.

There were genuine bright spots:

• EMC wheel and tire sales rose 5% to $57 million, with gross margin improving to 7.1% from 6.1%.
• Consumer gross margin excluding tariff refunds rose to 24.7% from 23.4%.
• SG&A fell to $46 million from $49 million.
• A Q3 tax expense of roughly $0.2 million, versus $4-5 million guided, likely flattered the bottom line, which tempers the EPS beat.

Cash flow is harder to read. The release cites $23 million of free cash flow from continuing operations. The call discussion referenced Q3 free cash flow of $10 million, down from $26 million in Q2, alongside continuing-operations operating cash flow of $29 million versus $19 million a year ago. The figures likely reflect different bases, and investors should reconcile them before drawing conclusions.

Guidance is the central tension. Including ITM, Titan now expects:

• Full-year 2026 sales of $1.85-1.87 billion, down from a prior $1.85-1.95 billion.
• Adjusted EBITDA of $91-101 million, below the floor of the prior range.
• Fourth-quarter sales of $410-430 million and Adjusted EBITDA of break-even to $7 million.

Roughly $10 million of that Q4 EBITDA is attributed to ITM, which implies the continuing wheel-and-tire business loses money in the quarter. Q4 2025 delivered about $10 million. Management's tone shifted markedly. Early in the year it framed 2025 as the trough and reinstated growth guidance. Now it calls 2026 the floor, acknowledges "false starts" in the ag recovery, and offers only cautious optimism for 2027. Additional pressures include:

• Energy and material inflation tied to the Iran war continues to outrun OEM contract pricing resets, a lag initially described as a Q2 timing issue.
• Brazil ag weakened sharply, with elevated inventories and weakness expected into Q1 2027.
• Expected tariff refunds were trimmed to about $6 million from $7-9 million.

The ITM sale is the most consequential strategic development. It narrows Titan's focus to wheels and tires, should reduce debt and working-capital intensity, and management expects no significant dis-synergies. Net debt has already fallen to $406 million from $441 million in Q1. Bears have legitimate ammunition, though. ITM contributes roughly $465-470 million of revenue and about $40 million of EBITDA this year, and its removal raises questions about the $250 million mid-cycle EBITDA target. On the positive side, management points to:

• Low channel inventories and an aging equipment fleet.
• Customer forecasts calling for growth in 2027.
• Consumer OEM platform wins expected to add sales next year.
• Capital-light vehicles such as the Roderas stake and the Titan-Yusheng JV.

Investor sentiment improved modestly, rising to 0.1103 from 0.0672, which leaves it mildly positive rather than enthusiastic. The stock has not shared that optimism. Shares closed at $6.62 before the report, down 11.6% since the open following the July release. That puts the stock 15.8% below its $7.86 200-day moving average and just 3.9% above the 52-week low of $6.37 set in August. It is also about 20.7% below the September peak of $8.35, so the stock entered earnings near the bottom of its inter-earnings range. The Earnings Whispers price, sequential growth, and AVWAP trend readings remain negative, consistent with a market that had already priced in much of the disappointment.

The bottom line is that Titan's narrower-than-expected loss is overshadowed by a guidance cut below the prior floor, a sharp ag margin decline, and an implied fourth-quarter loss in continuing operations. The ITM sale gives the company a cleaner balance sheet and a more focused story. However, it also shrinks the earnings base just as the ag recovery has slipped again to 2027, leaving the thesis dependent on a demand rebound that management has already mistimed once this year.